A Study Using [18F]F AraG PET to Evaluate Response to Checkpoint Inhibitor Therapy(CkIT) in Patients With Solid Tumors

Clinical trial NCT04260256 · TERMINATED

Trial details

NCT number: NCT04260256
Sponsor: CellSight Technologies, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Correlate Tracer Uptake to TCell Tumor Infiltration & CkIT Benefit

Start date: 2022-03-01
Primary completion: 2026-03-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.